Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis

Full Text:


The main target for COVID-19 is the lung with the development of acute respiratory failure. But the virus also displays tropism to the central nervous, muscle, and immune systems. The paper gives the data available in the literature on nervous system damage and the characteristics of clinical and magnetic resonance imaging manifestations of brain damage in COVID-19. Among the neurological symptoms of COVID-19, there may be stroke, encephalitis, and neuropathy. An account is given of the features of multiple sclerosis patient management during the COVID-19 pandemic depending on the risk of developing coronavirus infection.

About the Authors

A. N. Boyko
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center for the Brain and Neurotechnologies, Federal Medical Biological Agency of Russia;
Russian Federation

Department of Neurology, Neurosurgery, and Medical Genetics;
Department of Neuroimmunology

1, Ostrovityanov St, Moscow 117997;
1, Ostrovityanov St, Build. 10, Moscow 117997;

S. A. Sivertseva
Tyumen Regional Multiple Sclerosis Center;
Russian Federation
8/1, Yuri Semovskikh St., Tyumen 625000;

N. N. Spirin
Yaroslavl State Medical University, Ministry of Health of Russia
Russian Federation
5, Revolyutsionnaya St., Yaroslavl 150000



2. Palasca O, Santos A, Stolte C, et al. TISSUES 2.0: an integrative web resource on mammalian tissue expression. Database (Oxford). 2018 Jan 1;2018:bay028. doi: 10.1093/database/bay028.

3. Desforges M, Le Coupanec A, Stodola JK, et al. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014 Dec 19;194: 145-58. doi: 10.1016/j.virusres.2014.09.011. Epub 2014 Oct 2.

4. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.

5. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun; 92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.

6. Mao L, Wang M, Chen S, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study. MedRxiv preprint. doi: 10.1101/2020.02.22.20026500

7. International MG/COVID Working Group; Jacob S, Muppidi S, Guidon F, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.

8. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-ssociated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology 2020 Mar 31:201187.

9. Wei H, Yin H, Huang M, Guo Z. The 2019 novel coronavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020 May;267(5):1550-1553. doi: 10.1007/s00415-020-09773-9. Epub 2020 Feb 25.







For citations:

Boyko A.N., Sivertseva S.A., Spirin N.N. Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(1S):44-47. (In Russ.)

Views: 440

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)